UB Paderborn / Katalog / Suche / in CDI

Safety Issues of Maternal Drug Therapy During Breastfeeding

Clinical pharmacology and therapeutics, 2009-01, Vol.85 (1), p.20-22

2009

Volltextzugriff (PDF)

Advances in Pharmacogenetics and Pharmacogenomics

Journal of clinical pharmacology, 2000-09, Vol.40 (9), p.930-938

Vesell, Elliot S.

2000

Volltextzugriff (PDF)

Genetic Variation as a Guide to Drug Development

Science (American Association for the Advancement of Science), 1998-09, Vol.281 (5384), p.1820-1821

1998

Volltextzugriff (PDF)

Are the Elderly Underrepresented in Clinical Drug Trials?

Journal of clinical pharmacology, 1999-11, Vol.39 (11), p.1103-1108

1999

Volltextzugriff (PDF)

Recollections from the Kunkel Laboratory, 1956-1958

Lupus, 2003-01, Vol.12 (3), p.238-241

Vesell, E S

2003

Volltextzugriff (PDF)

Metabolism of Nicotine

Drug metabolism reviews, 1991, Vol.23 (1-2), p.3-41

1991

Volltextzugriff (PDF)

Pharmacogenetic perspectives gained from twin and family studies

Pharmacology & therapeutics (Oxford), 1989, Vol.41 (3), p.535-552

Vesell, Elliot S.

1989

Volltextzugriff (PDF)

Likelihood of NIH Extramural Funding

Science (American Association for the Advancement of Science), 1999-09, Vol.285 (5434), p.1674-1676

1999

Volltextzugriff (PDF)

Metabolism and disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone (NNK) in rhesus monkeys

Drug metabolism and disposition, 1999-04, Vol.27 (4), p.471

1999

Volltextzugriff (PDF)

Studies on pyrazinoylguanidine: a novel antihypertensive, hypoglycemic and lipolytic drug intended for adjunctive use in hypertensive patients with type 2 diabetes mellitus

Toxicology (Amsterdam), 2000-04, Vol.144 (1), p.5-11

2000

Volltextzugriff (PDF)

Underrepresentation of women in clinical drug trials

Clinical pharmacology and therapeutics, 1993-07, Vol.54 (1), p.11-15

1993

Volltextzugriff (PDF)

Pharmacokinetics of nicotine and 12 metabolites in the rat. Application of a new radiometric high performance liquid chromatography assay

Drug metabolism and disposition, 1988-01, Vol.16 (1), p.125

1988

Volltextzugriff (PDF)

Variables affecting nicotine metabolism

Pharmacology & therapeutics (Oxford), 1993-01, Vol.60 (3), p.461-500

1993

Volltextzugriff (PDF)

Therapeutic drug monitoring

Clinical pharmacology and therapeutics, 1988-04, Vol.43 (4), p.345-353

1988

Volltextzugriff (PDF)

Nicotine metabolism in stumptailed macaques, Macaca arctoides

Drug metabolism and disposition, 1991-09, Vol.19 (5), p.946

1991

Volltextzugriff (PDF)

Sexual dimorphism of nicotine metabolism and distribution in the rat. Studies in vivo and in vitro

Drug metabolism and disposition, 1988-11, Vol.16 (6), p.823

1988

Volltextzugriff (PDF)

Rates of excretion of cotinine, nicotine glucuronide, and 3-hydroxycotinine glucuronide in rat bile

Drug metabolism and disposition, 1993-09, Vol.21 (5), p.927

1993

Volltextzugriff (PDF)

The model drug approach in clinical pharmacology

Clinical pharmacology and therapeutics, 1991-09, Vol.50 (3), p.239-248

Vesell, Elliot S

1991

Volltextzugriff (PDF)

Genetic Risk Prediction: Individualized Variability in Susceptibility to Toxicants

Annual review of pharmacology and toxicology, 2013-01, Vol.53 (1), p.355-375

2013

Volltextzugriff (PDF)

Reflections from Distant Cuvettes

Drug metabolism reviews, 1996-01, Vol.28 (4), p.493-511

Vesell, Elliot s.

1996

Volltextzugriff (PDF)

Polymorphism of theophylline metabolism in man

The Journal of clinical investigation, 1985-05, Vol.75 (5), p.1415-1425

1985

Volltextzugriff (PDF)

Effect of cooking methods on the mutagenicity of food and on urinary mutagenicity of human consumers

Food and chemical toxicology, 1989, Vol.27 (10), p.657-666

1989

Volltextzugriff (PDF)

NIH Budget Grows, but Not R01 Success Rates

Science (American Association for the Advancement of Science), 2001-10, Vol.294 (5540), p.54-57

2001

Volltextzugriff (PDF)

Pyrazinoylguanidine: Antihypertensive, Hypocholesterolemic, and Renin Effects

Journal of clinical pharmacology, 1992-12, Vol.32 (12), p.1128-1134

1992

Volltextzugriff (PDF)

Acetylator Phenotype in Relation to Age and Gender in the Baltimore Longitudinal Study of Aging

Journal of clinical pharmacology, 1997-02, Vol.37 (2), p.83-91

1997

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Safety Issues of Maternal Drug Therapy During Breastfeeding

Advances in Pharmacogenetics and Pharmacogenomics

Genetic Variation as a Guide to Drug Development

Are the Elderly Underrepresented in Clinical Drug Trials?

Recollections from the Kunkel Laboratory, 1956-1958

Metabolism of Nicotine

Pharmacogenetic perspectives gained from twin and family studies

Likelihood of NIH Extramural Funding

Metabolism and disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone (NNK) in rhesus monkeys

Studies on pyrazinoylguanidine: a novel antihypertensive, hypoglycemic and lipolytic drug intended for adjunctive use in hypertensive patients with type 2 diabetes mellitus

Underrepresentation of women in clinical drug trials

Pharmacokinetics of nicotine and 12 metabolites in the rat. Application of a new radiometric high performance liquid chromatography assay

Variables affecting nicotine metabolism

Therapeutic drug monitoring

Nicotine metabolism in stumptailed macaques, Macaca arctoides

Sexual dimorphism of nicotine metabolism and distribution in the rat. Studies in vivo and in vitro

Rates of excretion of cotinine, nicotine glucuronide, and 3-hydroxycotinine glucuronide in rat bile

The model drug approach in clinical pharmacology

Genetic Risk Prediction: Individualized Variability in Susceptibility to Toxicants

Reflections from Distant Cuvettes

Polymorphism of theophylline metabolism in man

Effect of cooking methods on the mutagenicity of food and on urinary mutagenicity of human consumers

NIH Budget Grows, but Not R01 Success Rates

Pyrazinoylguanidine: Antihypertensive, Hypocholesterolemic, and Renin Effects

Acetylator Phenotype in Relation to Age and Gender in the Baltimore Longitudinal Study of Aging

Suchergebnisse filtern